The Joint 24th Medicines for Europe and 21st IGBA Annual Conference will bring together over 300 experts including medicine manufacturers, stakeholders and governments to evaluate market trends, innovative commercial strategies, challenges for the pharmaceutical sector and new opportunities to improve access to medicines for patients. At this unique event, the participants will not only gain new information, but will also have the opportunity to network in the beautiful capital of Hungary, Budapest!

• Get updates on the latest development and market trends in the Generic, Biosimilar and Value Added medicines industry
• Meet high-level speakers from Europe, Brazil, US, Japan, Taiwan, Russia, Canada, Malaysia, South Africa, India and many more countries to understand the global relevance of Generic, Biosimilar and Value Added Medicines
• Network with policy-makers, regulators, payers and peers
• Discover business opportunities in pharmaceutical markets across the world

• Sustainability of the off-patent markets
• Political decisions impacting the supply of medicines
• The fight against counterfeit medicines
• How to keep up in providing data, recognising its value and making the best use of it
• How to manage selective transparency, commoditisation, shortages
• The impact of international agreements on access to medicines
• Models to bring better medicines to patients
• Defining a future where trust and regulatory efficiency translate into patient access
• Increasing patient access to specialty medicines

Check the PROGRAMME